...

Celexo EXO-CICA 2v

Celexo EXO-CICA 2v

ABio materials Co. is a biotechnology-driven manufacturer specializing in advanced biomaterials for medical aesthetics, dermatology, and tissue regeneration. Operating pharmaceutical-grade facilities in Korea under ISO 13485 and GMP standards, the company transforms research into clinical-grade products that deliver measurable results. All products are US FDA listed, with ABio materials USA Inc. serving as the exclusive importer and distributor throughout North America.

Celexo Exo Cica addresses inflammatory skin conditions, post-procedural sensitivity, and impaired barrier function through exosome-mediated cellular signaling. The formulation contains plant-derived exosomes at concentrations reaching 5 billion particles per milliliter, combined with Centella Asiatica extract in a 4:1 ratio. The delivery matrix maintains physiological pH between 5.0 and 6.0, formulated specifically for compromised and reactive skin states.

Core Values: Science First formulations grounded in peer-reviewed research and cellular biology. Professional Integrity serving only licensed professionals. Sustainable Innovation environmentally responsible manufacturing practices.

[guest_login_cta]

Description

Key Benefits of Using Celexo Blacklabel

Multi-Pathway Regeneration:

Triple exosome system simultaneously addresses collagen loss, cellular aging, oxidative damage, and matrix deterioration through comprehensive signaling beyond single-mechanism approaches.

Quantified Performance:

Formulation demonstrates a 300 to 400 percent increase in collagen expression in controlled studies, supporting measurable improvements in skin density and wrinkle reduction.

Clinical Concentration:

Total exosome levels reaching 30 billion particles per milliliter represent significantly higher bioactive density, enabling measurable clinical outcomes.

Cumulative Effects:

Regular application supports sustained cellular signaling over time, with improvements continuing beyond initial treatment as tissue remodeling progresses.

Treatment Enhancement:

Amplifies outcomes when combined with microneedling, RF, PRP therapies, and laser treatments through synergistic mechanisms.

Quality Manufacturing:

Produced under ISO 13485 and GMP standards with US FDA listing, complete batch characterization, and pharmaceutical-grade specifications.

 

Common Use Cases:

  • Post-microneedling or RF microneedling enhancement at depths between 0.5 and 2.5mm
  • Adjunct to laser and RF treatments for thermal-induced collagen support
  • Combination with PRP or PRF for a synergistic growth factor environment
  • Intensive standalone anti-aging protocols with twice-daily application
  • Preventive maintenance programs supporting sustained collagen synthesis
  • Pre-event skin quality improvement for rapid visible enhancement

 

Ideal Use Environment

Celexo Blacklabel is not a consumer product and is intended exclusively for application by licensed professionals in medical or aesthetic clinical environments.

Recommended For Use By:

  • Board-certified dermatologists specializing in regenerative dermatology
  • Plastic and cosmetic surgeons
  • Advanced aesthetic practitioners with exosome technology training
  • Medical spas with physician oversight
  • Clinical research teams investigating regenerative applications

 

Each formulation is manufactured under controlled conditions in Korea, adhering to rigorous standards for purity, safety, and consistency. The product requires refrigerated storage between 2 and 8 degrees Celsius. Complete technical documentation is available to licensed professionals.

Call Now Button